BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 36168098)

  • 1. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
    Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K;
    Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection - A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis.
    Werner RN; Gaskins M; Nast A; Dressler C
    PLoS One; 2018; 13(12):e0208107. PubMed ID: 30507962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
    Traeger MW; Guy R; Asselin J; Patel P; Carter A; Wright EJ; Grulich A; McManus H; Fairley CK; Chow EPF; McNulty A; Finlayson R; Bell C; Owen L; Marshall L; Russell D; O'Donnell D; Donovan B; Hellard ME; Stoové MA;
    Lancet Infect Dis; 2022 Aug; 22(8):1231-1241. PubMed ID: 35643090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections].
    Schmidt D; Kollan C; Schewe K; Hanhoff N; Rüsenberg R; Friebe M; Schikowski T; Schink SB; Marcus U; Koppe U; Jansen K; Streeck H; Ottensmeyer P; An der Heiden M; Bannert N; M'Bayo R; Ceres M; Weber L; Sweers H; Schmidt AJ; Tietz H; Danan E; Bendig J; Kloep S; Neumann A; Valbert F; Wasem J; Bartmeyer B; Bremer V;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Sep; 66(9):1008-1018. PubMed ID: 37436444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.
    Kiefer EM; Ross KS; Santos AC; Barney MR; McCormick TJ; Chow DC; Shikuma CM
    Hawaii J Health Soc Welf; 2021 Jul; 80(7):148-154. PubMed ID: 34278321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexually Transmitted Infection Screening Among Gay, Bisexual, and Other Men Who Have Sex With Men Prescribed Pre-exposure Prophylaxis in Baltimore City, Maryland.
    Schumacher C; Wu L; Chandran A; Fields E; Price A; Greenbaum A; Jennings JM;
    Clin Infect Dis; 2020 Dec; 71(10):2637-2644. PubMed ID: 31761944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men.
    van Wees DA; Diexer S; Rozhnova G; Matser A; den Daas C; Heijne J; Kretzschmar M
    Sex Transm Infect; 2022 Sep; 98(6):395-400. PubMed ID: 34716228
    [No Abstract]   [Full Text] [Related]  

  • 8. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.
    Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C;
    BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre-exposure prophylaxis by statutory health insurance in Germany.
    Schuettfort G; Groh A; Kann G; Haberl A; Herrmann E; Wetzstein N; Vehreschild MJGT; Stephan C
    HIV Med; 2023 Feb; 24(2):163-169. PubMed ID: 35859321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    van den Elshout MAM; Wijstma ES; Boyd A; Jongen VW; Coyer L; Anderson PL; Davidovich U; de Vries HJC; Prins M; Schim van der Loeff MF; Hoornenborg E;
    PLoS Med; 2024 May; 21(5):e1004328. PubMed ID: 38718068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
    Luetkemeyer AF; Donnell D; Dombrowski JC; Cohen S; Grabow C; Brown CE; Malinski C; Perkins R; Nasser M; Lopez C; Vittinghoff E; Buchbinder SP; Scott H; Charlebois ED; Havlir DV; Soge OO; Celum C;
    N Engl J Med; 2023 Apr; 388(14):1296-1306. PubMed ID: 37018493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
    Streeck H; Jansen K; Crowell TA; Esber A; Jessen HK; Cordes C; Scholten S; Schneeweiss S; Brockmeyer N; Spinner CD; Bickel M; Esser S; Hartikainen J; Stoehr A; Lehmann C; Marcus U; Vehreschild JJ; Knorr A; Brillen AL; Tiemann C; Robb ML; Michael NL
    Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
    Hovaguimian F; Kouyos RD; Kusejko K; Schmidt AJ; Tarr PE; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Darling KEA; Depmeier C; Läuchli S; Reinacher M; Rasi M; Nicca D; Bruggmann P; Haerry D; Bize R; Low N; Vock F; El Amari EB; Böni J; Bosshard PP; Fehr JS; Hampel B;
    HIV Med; 2024 Jan; 25(1):117-128. PubMed ID: 37771207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexually transmitted infection screening, prevalence and incidence among South African men and transgender women who have sex with men enrolled in a combination HIV prevention cohort study: the Sibanye Methods for Prevention Packages Programme (MP3) project.
    Jones J; Sanchez TH; Dominguez K; Bekker LG; Phaswana-Mafuya N; Baral SD; McNaghten AD; Kgatitswe LB; Valencia R; Yah CS; Zahn R; Siegler AJ; Sullivan PS
    J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25594. PubMed ID: 33000886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections.
    Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort.
    Nozza S; Raccagni AR; Lolatto R; Ceccarelli D; Galli L; Alberton F; Bruzzesi E; Canetti D; Strano M; Ripa M; Bertoni C; Castagna A
    BMJ Open; 2022 Dec; 12(12):e067261. PubMed ID: 36600429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Tabatabavakili S; Aleyadeh W; Cerrocchi O; Janssen HLA; Hansen BE; Bogoch II; Feld JJ;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):674-681. PubMed ID: 33737225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis.
    Ong JJ; Baggaley RC; Wi TE; Tucker JD; Fu H; Smith MK; Rafael S; Anglade V; Falconer J; Ofori-Asenso R; Terris-Prestholt F; Hodges-Mameletzis I; Mayaud P
    JAMA Netw Open; 2019 Dec; 2(12):e1917134. PubMed ID: 31825501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.